InhaleRx Ltd (ASX: IRX) is a biotechnology and healthcare company based in Australia, founded in 2020. The company's mission is to provide innovative inhaled therapies to patients in an affordable and high-quality format, supported by strong clinical evidence. InhaleRx aims to achieve this by partnering with innovators and educators in the technical and therapeutic fields to deliver breakthrough therapies that provide added value for patients, doctors, business partners, governments, and stakeholders alike.
With the slogan "Providing the most innovative inhaled therapies in the world," InhaleRx Ltd is dedicated to revolutionizing inhaled medication systems and aims to make a significant impact in the healthcare industry. While specific details about the last investment and investors are not available at this time, the company's focus on delivering unique benefits to patients through inhaled therapies indicates strong potential for growth and innovation within the biotechnology and healthcare sectors.
There is no investment information
No recent news or press coverage available for InhaleRx Ltd (ASX: IRX).